Regencell Bioscience (RGC)

• Market cap: $7.74B
• 1 day: -2.52%
• 5 days: -19.58%
• 1 month: 90.61%
• 3 months: 4,123.56%
• 6 months: 11,065.10%
• Year to date: 12,246.47%
• 1 year: 14,485.78%
• 5 years: 5,567.62%
• 10 years: 5,567.62%
• Sector: Healthcare
• Industry: Drug Manufacturers - Specialty & Generic

About: Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.

Employees: 12

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

200% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 1

80% more capital invested

Capital invested by funds: $156K [Q4 2024] → $281K (+$125K) [Q1 2025]

67% more funds holding

Funds holding: 3 [Q4 2024] → 5 (+2) [Q1 2025]

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

0.17% less ownership

Funds ownership: 0.24% [Q4 2024] → 0.07% (-0.17%) [Q1 2025]